Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 7/20 | 0.39 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.39 |
| ▸ | FURIN | P09958 | 6/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | F10 | P00742 | 1/20 | 0.36 |
| ▸ | TLR2 | O60603 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22674921 | 0.88 | NMT2 (0.40) | ITGB3ITGA2BFURINCTSSCTSK | |
| SCHEMBL22674899 | 0.84 | FURIN (0.42) | FURINTLR2 | |
| SCHEMBL30435754 | 0.80 | NOD1 (0.46) | FURINTLR2 | |
| SCHEMBL29503454 | 0.79 | SLC6A5 (0.48) | ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL10864620 | 0.79 | NOD1 (0.53) | ITGB3ITGA2BTLR2 | |
| SCHEMBL7782848 | 0.79 | CTSK (0.49) | ITGB3ITGA2BCTSSCTSKTLR2 | |
| SCHEMBL2804552 | 0.78 | CTSK (0.49) | ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL12015102 | 0.78 | CTSK (0.49) | ITGB3ITGA2BCTSSCTSK | |
| SCHEMBL13997353 | 0.77 | ITGB3 (0.48) | ITGB3ITGA2BCTSSCTSKTLR2 | |
| SCHEMBL29918164 | 0.77 | NPSR1 (0.40) | CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200361987-A1 | DEUTERATED TETRAPEPTIDES THAT TARGET MITOCHONDRIA | STEALTH BIOTHERAPEUTICS INC. | 2020-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200361987-A1 | DEUTERATED TETRAPEPTIDES THAT TARGET MITOCHONDRIA | ABAT, SSBP1, PDF | ITGB3 4715/4885ITGA2B 4844/4885FURIN 2315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.